Stock PTPI PETROS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Petros Pharmaceuticals, Inc.

Equities

PTPI

US71678J2096

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-07-05 EDT 		5-day change 1st Jan Change
0.415 USD -2.15% Intraday chart for Petros Pharmaceuticals, Inc. -9.29% -70.57%
05-29 Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) OTC Switch CI
05-15 Petros Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA OTC Switch
AQ
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
AQ
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
AQ
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA through New Agreement with Lemonaid Health
AQ
BestGrowthStocks.Com Issues Comprehensive Analysis of Petros Pharmaceuticals Inc
AQ
Thinking about buying stock in Helius Medical Technologies, Peraso, GDS Holdings, Everbridge, or Petros Pharmaceuticals?
PR
Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA Rx-to-OTC Switch
AQ
Petros Pharmaceuticals Demonstrates Positive Results Following Successful Completion of Initial Cohort of Phase 2 Equivalent Self-Selection Study for STENDRA Rx-to-OTC Switch
AQ
Petros Pharmaceuticals Successfully Completes Important Study in Effort to Make STENDRA the First Erectile Dysfunction Medication to Achieve OTC Status
AQ
Petros Pharmaceuticals Partners with Blockbuster Cholesterol Drug(1) Crestor's OTC Switch Technology Provider
AQ
Petros Pharmaceuticals Petros Pharmaceuticals Developing Artificial Intelligence Technology for Phase 2 Equivalent Study for STENDRA
AQ
Petros Pharmaceuticals to Present at the LD Micro Main Event XVI
AQ
Petros Pharmaceuticals : Modification to Rights of Security Holders - Form 8-K
PU
Petros Pharmaceuticals Provides Letter to Shareholders
AQ
CapitalGainsReport: Men's Wellness Watchlist (MGRX, OTRK, HIMS, PTPI)
AQ
Men's Wellness Stocks Watchlist (MGRX, OTRK, HIMS, PTPI)
AQ
CapitalGainsReport: Unlocking Opportunities in Men's Health Stocks (MGRX, HIMS, TDOC, PTPI)
AQ
PETROS PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
PETROS PHARMACEUTICALS, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
PETROS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PTPI Stock
  4. News Petros Pharmaceuticals, Inc.
  5. Press Releases